Statutory Instruments
2017 No. 1114
Dangerous Drugs
The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2017
Made
15th November 2017
Coming into force
27th November 2017
At the Court at Buckingham Palace, the 15th day of November 2017
Present,
The Queen’s Most Excellent Majesty in Council
In accordance with section 2(5) of the Misuse of Drugs Act 1971( 1 ) a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and approved by a resolution of each House of Parliament.
Accordingly, Her Majesty, in exercise of the powers conferred upon Her by section 2(2) of that Act, is pleased, by and with the advice of Her Privy Council, to order as follows:
Citation and commencement
1. This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2017 and comes into force on the 27th November 2017.
Amendment to the Misuse of Drugs Act 1971
2. The following amendment is made to Schedule 2 to the Misuse of Drugs Act 1971.
3. In paragraph 1(a) of Part 2 (which specifies the drugs which are subject to control under that Act as Class B drugs) after “Methylphenobarbitone” insert—
“ N -methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine or MPA). ” .
Ceri King
Deputy Clerk of the Privy Council
1971 c. 38 . Schedule 2 has been amended by section 21 of the Drugs Act 2005 (c. 17) and S.I. 1973/771 , 1975/421 , 1977/1243 , 1979/299 , 1983/765 , 1984/859 , 1985/1995 , 1986/2230 , 1989/1340 , 1990/2589 , 1995/1966 , 1996/1300 , 1998/750 , 2001/3932 , 2003/1243 , 2003/3201 , 2005/3178 , 2006/3331 , 2008/3130 , 2009/3209 , 2010/1207 , 2010/1833 , 2011/744 , 2012/1390 , 2013/239 , 2014/1106 , 2014/1352 , 2014/3271 , 2015/215 , 2016/1109 and 2017/634 .